Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes insulin resistance during obesity
暂无分享,去创建一个
C. Weber | O. Soehnlein | E. Lutgens | R. Gallo | C. Silvestre-Roig | P. Kusters | S. Aarts | M. den Toom | Q. Braster | H. Hartwig | Myrthe den Toom
[1] Qilong Wang,et al. Myeloperoxidase Deletion Prevents High-Fat Diet–Induced Obesity and Insulin Resistance , 2014, Diabetes.
[2] J. Kahlenberg,et al. Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease , 2013, The Journal of Immunology.
[3] T. Chavakis,et al. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance , 2013, Thrombosis and Haemostasis.
[4] C. Weber,et al. Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice , 2012, Circulation research.
[5] O. Soehnlein,et al. Neutrophilic granulocytes – promiscuous accelerators of atherosclerosis , 2011, Thrombosis and Haemostasis.
[6] T. Gries,et al. Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia , 2011, Science Translational Medicine.
[7] T. Ottenhoff,et al. LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature , 2010, The Journal of Immunology.
[8] A. Zernecke,et al. Neutrophil secretion products pave the way for inflammatory monocytes. , 2008, Blood.
[9] Ji Ming Wang,et al. Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.